SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-14-027207
Filing Date
2014-05-02
Accepted
2014-05-02 16:34:35
Documents
5
Period of Report
2014-06-09
Effectiveness Date
2014-05-02

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A v377105_def14a.htm DEF 14A 536573
2 GRAPHIC tarrow.jpg GRAPHIC 1143
3 GRAPHIC tpg49a.jpg GRAPHIC 3754
4 GRAPHIC tpg49b.jpg GRAPHIC 3379
5 GRAPHIC tpg49c.jpg GRAPHIC 4612
  Complete submission text file 0001144204-14-027207.txt   556019
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 14809873
SIC: 2834 Pharmaceutical Preparations